📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
45%
💰 Capital Raise
55%
• Critical: only 2.0 months cash remaining
📉 Score Deterioration
50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
15%
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$4.34M
Shares Outstanding2.61M
Float2.40M
Cash$511.7K
Debt$26.44M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 57.7% shares (2025Q4 vs prior)
11 institutional holders · 205.9K shares
#1
Anson Funds Management LP
71.8K shares
#2
JANE STREET GROUP, LLC
58.3K shares
#3
UBS Group AG
31.4K shares
+ 8 more holders Sign up free to view →
📉 Short Interest
Short Interest181.5K
Days to Cover1.0
% of Float7.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RENX
📊 RENX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RENX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 RENX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.